Ozempic and Thyroid Cancer: What Is the Real Risk?
A black box warning exists for semaglutide and thyroid cancer. Here is what the evidence actually shows, why the warning...
Evidence-based, medically reviewed articles on metabolic health, GLP-1 science, nutrition and sustainable weight management.
A black box warning exists for semaglutide and thyroid cancer. Here is what the evidence actually shows, why the warning...
GLP-1 and GIP are two gut hormones that regulate appetite and insulin. Understanding both explains why tirzepatide outpe...
Mounjaro (tirzepatide) produces more weight loss than Ozempic (semaglutide) on average. Here is what the evidence shows...
Wegovy (semaglutide 2.4 mg) and Mounjaro/Zepbound (tirzepatide 15 mg) are the two leading weight loss drugs. Here is wha...
Metformin is older and cheaper. Ozempic is newer and more effective for weight loss. Here is how they compare and when e...
Phentermine is cheaper and works faster short-term. Ozempic produces more sustained weight loss over months. Here is the...
Certain foods stimulate your gut to release more GLP-1 naturally. Here is what the evidence shows about protein, fibre,...
Most people regain significant weight after stopping Ozempic. Here is what the STEP 4 trial shows and how to slow regain...
Weight loss on Ozempic plateaus at 60 to 68 weeks. Here is why it happens, whether the drug is still working, and what t...
Physician-authored articles on GLP-1, metabolism and sustainable fat loss, delivered to your inbox.
✓ Subscribed! Check your inbox.
No spam. Unsubscribe anytime.